128 related articles for article (PubMed ID: 8992883)
1. Effects of synthetic peptido-leukotrienes on bone resorption in vitro.
Garcia C; Qiao M; Chen D; Kirchen M; Gallwitz W; Mundy GR; Bonewald LF
J Bone Miner Res; 1996 Apr; 11(4):521-9. PubMed ID: 8992883
[TBL] [Abstract][Full Text] [Related]
2. Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo.
Garcia C; Boyce BF; Gilles J; Dallas M; Qiao M; Mundy GR; Bonewald LF
J Bone Miner Res; 1996 Nov; 11(11):1619-27. PubMed ID: 8915769
[TBL] [Abstract][Full Text] [Related]
3. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
Bäck M
Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
[TBL] [Abstract][Full Text] [Related]
4. [Leukotrienes: potential therapeutic targets in cardiovascular diseases].
Bäck M
Bull Acad Natl Med; 2006 Oct; 190(7):1511-8; discussion 1518-21. PubMed ID: 17450683
[TBL] [Abstract][Full Text] [Related]
5. Characterization of specific binding sites for cysteinyl leukotrienes in sheep lung.
Metters KM; Gareau Y; Lord A; Rochette C; Sawyer N
J Pharmacol Exp Ther; 1994 Jul; 270(1):399-406. PubMed ID: 8035338
[TBL] [Abstract][Full Text] [Related]
6. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
7. Characterization of guinea pig myocardial leukotriene C4 binding sites. Regulation by cations and sulfhydryl-directed reagents.
Hogaboom GK; Mong S; Stadel JM; Crooke ST
Mol Pharmacol; 1985 Feb; 27(2):236-45. PubMed ID: 2982090
[TBL] [Abstract][Full Text] [Related]
8. Human cord blood monocytes undergo terminal osteoclast differentiation in vitro in the presence of culture medium conditioned by giant cell tumor of bone.
Roux S; Quinn J; Pichaud F; Orcel P; Chastre E; Jullienne A; De Vernejoul MC
J Cell Physiol; 1996 Sep; 168(3):489-98. PubMed ID: 8816903
[TBL] [Abstract][Full Text] [Related]
9. Binding of radiolabeled high affinity antagonist to leukotriene D4 receptor in guinea pig lung membranes: interconversion of agonist-receptor binding affinity states.
O'Sullivan BP; Mong S
Mol Pharmacol; 1989 Jun; 35(6):795-802. PubMed ID: 2543913
[TBL] [Abstract][Full Text] [Related]
10. Competition of leukotrienes and ICI-198,615 for [3H]LTD4 binding sites in guinea pig lung membranes suggests the involvement of two LTD4 receptor subtypes.
Shirley JT; Cheng JB
J Pharmacol Exp Ther; 1991 Aug; 258(2):531-6. PubMed ID: 1650832
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells.
Thivierge M; Stankova J; Rola-Pleszczynski M
J Allergy Clin Immunol; 2006 May; 117(5):1155-62. PubMed ID: 16675346
[TBL] [Abstract][Full Text] [Related]
12. Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand.
Kanaoka Y; Maekawa A; Austen KF
J Biol Chem; 2013 Apr; 288(16):10967-72. PubMed ID: 23504326
[TBL] [Abstract][Full Text] [Related]
13. Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity.
Kanatani M; Sugimoto T; Kaji H; Kobayashi T; Nishiyama K; Fukase M; Kumegawa M; Chihara K
J Bone Miner Res; 1995 Nov; 10(11):1681-90. PubMed ID: 8592944
[TBL] [Abstract][Full Text] [Related]
14. Everolimus suppresses cancellous bone loss, bone resorption, and cathepsin K expression by osteoclasts.
Kneissel M; Luong-Nguyen NH; Baptist M; Cortesi R; Zumstein-Mecker S; Kossida S; O'Reilly T; Lane H; Susa M
Bone; 2004 Nov; 35(5):1144-56. PubMed ID: 15542040
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of 3,5,3'-triiodothyroacetic acid and triiodothyronine on bone resorption in cultured fetal rat long bones and neonatal mouse calvariae.
Kawaguchi H; Pilbeam CC; Woodiel FN; Raisz LG
J Bone Miner Res; 1994 Feb; 9(2):247-53. PubMed ID: 8140938
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of amylin in bone.
Tamura T; Miyaura C; Owan I; Suda T
J Cell Physiol; 1992 Oct; 153(1):6-14. PubMed ID: 1325980
[TBL] [Abstract][Full Text] [Related]
17. Bone resorption by isolated chick osteoclasts in culture is stimulated by murine spleen cell supernatant fluids (osteoclast-activating factor) and inhibited by calcitonin and prostaglandin E2.
de Vernejoul MC; Horowitz M; Demignon J; Neff L; Baron R
J Bone Miner Res; 1988 Feb; 3(1):69-80. PubMed ID: 3264994
[TBL] [Abstract][Full Text] [Related]
18. Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer.
Yoneda T; Williams P; Rhine C; Boyce BF; Dunstan C; Mundy GR
Cancer Res; 1995 May; 55(9):1989-93. PubMed ID: 7728770
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoids stimulate resorption in fetal rat parietal bones in vitro.
Gronowicz G; McCarthy MB; Raisz LG
J Bone Miner Res; 1990 Dec; 5(12):1223-30. PubMed ID: 2127506
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of a mouse osteoclast-like multinucleated cell population.
Akatsu T; Tamura T; Takahashi N; Udagawa N; Tanaka S; Sasaki T; Yamaguchi A; Nagata N; Suda T
J Bone Miner Res; 1992 Nov; 7(11):1297-306. PubMed ID: 1281605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]